Relapsed/Refractory B Cell Malignancies (DBCOND0080947)
Identifiers
- Synonyms
- Relapsed/Refractory B-cell Malignancies
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT02825836 Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects No drug interventions treatment 1 / 2 active_not_recruiting NCT02457559 Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies treatment 1 completed NCT05780034 A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies No drug interventions treatment 1 recruiting NCT04861779 A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies No drug interventions treatment 1 unknown_status NCT04943016 CD19 CAR T Cells in Children and Adults With Relapsed or Refractory CD19 Positive B Cell Malignancies No drug interventions treatment 1 not_yet_recruiting NCT04689308 This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies No drug interventions treatment 1 unknown_status